Page 41 - EJMO-9-2

Eurasian Journal of
Medicine and Oncology Gut microbiome effects on obesity

N Engl J Med. 2023;389(6):514-526. 71. Martínez GJ, Robertson S, Barraclough J, et al. Colchicine
acutely suppresses local cardiac production of inflammatory
doi: 10.1056/NEJMoa2301972
cytokines in patients with an acute coronary syndrome. J Am
61. Rosenstock J, Wysham C, Frías JP, et al. Efficacy and safety of Heart Assoc Cardiovasc Cerebrovasc Dis. 2015;4(8):e002128.
a novel dual GIP and GLP-1 receptor agonist tirzepatide in
patients with type 2 diabetes (SURPASS-1): A double-blind, doi: 10.1161/JAHA.115.002128
randomised, phase 3 trial. Lancet. 2021;398(10295):143-155. 72. Demidowich AP, Wolska A, Wilson SR, et al. Colchicine’s
effects on lipoprotein particle concentrations in adults with
doi: 10.1016/S0140-6736(21)01324-6
metabolic syndrome: A secondary analysis of a randomized
62. Tucker JAL, Bornath DPD, McCarthy SF, Hazell TJ. Leptin controlled trial. J Clin Lipidol. 2019;13(6):1016-1022.e2.
and energy balance: Exploring Leptin’s role in the regulation
of energy intake and energy expenditure. Nutr Neurosci. doi: 10.1016/j.jacl.2019.10.011
2024;27(1):87-95. 73. Patel TP, Levine JA, Elizondo DM, et al. Immunomodulatory
effects of colchicine on PBMC subpopulations in human
doi: 10.1080/1028415X.2022.2161135
obesity: Data from a randomized controlled trial. Obesity
63. Mandel SJ, Brent GA, Larsen PR. Levothyroxine therapy (Silver Spring). 2023;31(2):466-478.
in patients with thyroid disease. Ann Intern Med. doi: 10.1002/oby.23632
1993;119(6):492-502.
74. UNC Carolina Population Center, Global Food Research
doi: 10.7326/0003-4819-119-6-199309150-00009
Program. Sugary Drink Taxes around the World; 2021.
64. Ruhla S, Arafat AM, Osterhoff M, et al. Levothyroxine Available from: https://www.globalfoodresearchprogram.
medication is associated with adiposity independent of org/wp-content/uploads/2021/09/sugarydrink_tax_maps_
TSH. Exp Clin Endocrinol Diabetes. 2012;120(6):351-354. ppts_2021_september.pdf [Last accessed on 2024 Dec 05].
doi: 10.1055/s-0032-1312599 75. Andreyeva T, Marple K, Marinello S, Moore TE, Powell LM.
65. Medici BR, Nygaard B, Cour JL, et al. Effects of levothyroxine Outcomes following taxation of sugar-sweetened beverages:
substitution therapy on hunger and food intake in individuals A systematic review and meta-analysis. JAMA Netw Open.
with hypothyroidism. Endocr Connect. 2023;12:e230314. 2022;5(6):e2215276.
doi: 10.1530/EC-23-0314 doi: 10.1001/jamanetworkopen.2022.15276
66. Knudsen LB, Lau J. The discovery and development of 76. Itria A, Borges SS, Rinaldi AEM, Nucci LB, Enes CC. Taxing
liraglutide and semaglutide. Front Endocrinol. 2019;10:155. sugar-sweetened beverages as a policy to reduce overweight
and obesity in countries of different income classifications:
doi: 10.3389/fendo.2019.00155 A systematic review. Public Health Nutr. 2021;24(16):5550-5560.
67. Kosiborod MN, Petrie MC, Borlaug BA, et al. Semaglutide doi: 10.1017/S1368980021002901
in patients with obesity-related heart failure and type 2
diabetes. N Engl J Med. 2024;390(15):1394-1407. 77. Gebrayel P, Nicco C, Al Khodor S, et al. Microbiota medicine:
Towards clinical revolution. J Transl Med. 2022;20(1):111.
doi: 10.1056/NEJMoa2313917
doi: 10.1186/s12967-022-03296-9
68. Wilding JPH, Batterham RL, Calanna S, et al. Once-weekly
semaglutide in adults with overweight or obesity. N Engl J 78. Retnakumar RJ, Nath AN, Nair GB, Chattopadhyay S.
Med. 2021;384(11):989-1002. Gastrointestinal microbiome in the context of Helicobacter
pylori infection in stomach and gastroduodenal diseases.
doi: 10.1056/NEJMoa2032183 Prog Mol Biol Transl Sci. 2022;192(1):53-95.
69. Zhou Q, Lei X, Fu S, et al. Efficacy and safety of tirzepatide, doi: 10.1016/bs.pmbts.2022.07.001
dual GLP-1/GIP receptor agonists, in the management
of type 2 diabetes: A systematic review and meta-analysis 79. Sender R, Fuchs S, Milo R. Revised estimates for the
of randomized controlled trials. Diabetol Metab Syndr. number of human and bacteria cells in the body. PLoS Biol.
2023;15(1):222. 2016;14(8):e1002533.
doi: 10.1186/s13098-023-01198-4 doi: 10.1371/journal.pbio.1002533
80. Scheithauer TPM, Rampanelli E, Nieuwdorp M, et al.
70. Raju NC, Yi Q, Nidorf M, Fagel ND, Hiralal R,
Eikelboom JW. Effect of colchicine compared with placebo Gut microbiota as a trigger for metabolic inflammation in
on high sensitivity C-reactive protein in patients with acute obesity and type 2 diabetes. Front Immunol. 2020;11:571731.
coronary syndrome or acute stroke: A pilot randomized doi: 10.3389/fimmu.2020.571731
controlled trial. J Thromb Thrombolysis. 2012;33(1):88-94.
81. Yun L, Li W, Wu T, Zhang M. Effect of sea cucumber
doi: 10.1007/s11239-011-0637-y peptides on the immune response and gut microbiota

Volume 9 Issue 2 (2025) 33 doi: 10.36922/ejmo.8318